Analyst Ratings Coverage:
Morgan Stanley & Co. – Equal-Weight (USD 105 to USD 106):
Morgan Stanley has maintained its “Equal-Weight” rating on Oracle’s stock, with a slight increase in the target price from USD 105 to USD 106. An “Equal-Weight” rating typically suggests that the stock is expected to perform in line with the broader market. This change reflects a marginal upward adjustment in their price target, indicating a modestly more positive outlook for Oracle’s stock.
Monness, Crespi, Hardt & Co. – Downgraded to Neutral:
Monness, Crespi, Hardt & Co. downgraded Oracle from their previous rating to “Neutral.” This shift suggests a more cautious stance on Oracle’s stock. A “Neutral” rating typically implies that the stock is expected to perform in line with market averages, without a strong bias towards either a positive or negative outlook.
UBS – Buy (USD 140 to USD 135):
UBS has maintained its “Buy” rating on Oracle’s stock but has slightly reduced the target price from USD 140 to USD 135. A “Buy” rating indicates that UBS believes Oracle’s stock has the potential for positive returns. The decrease in the target price may suggest a more conservative outlook, although the overall sentiment remains positive.
Barclays – Overweight (USD 150 ? USD 147):
Barclays has maintained its “Overweight” rating on Oracle’s stock with a slight decrease in the target price from USD 150 to USD 147. An “Overweight” rating typically implies that the stock is expected to outperform the market. The reduction in the target price might indicate a slight adjustment in expectations, but the positive stance on the stock remains.
Evercore ISI – In-Line (USD 125 to USD 131):
Evercore ISI has maintained its “In-Line” rating on Oracle’s stock, with an increased target price from USD 125 to USD 131. An “In-Line” rating suggests that the stock is expected to perform in line with market averages. The higher target price reflects a slightly more optimistic view of Oracle’s potential.
D. A. Davidson & Co. – Neutral (USD 115 to USD 104):
D. A. Davidson & Co. has maintained its “Neutral” rating on Oracle’s stock but has significantly reduced the target price from USD 115 to USD 104. This substantial reduction in the target price may indicate a more cautious outlook on Oracle’s stock and suggests that it is expected to perform in line with the market, without a strong bias towards either a positive or negative stance.
Oracle Stock Analysis & Forecast
Analyst Target Price: According to the consensus of 22 analysts, the average target price for Oracle Corporation is anticipated to reach USD 123.18 over the next 12 months. This target price represents the level at which analysts believe the stock should trade in the foreseeable future. It reflects their collective assessment of Oracle’s financial health, growth prospects, and overall market conditions.
Average Analyst Rating: The average analyst rating for Oracle Corporation is categorized as “Buy.” This rating indicates that the majority of analysts covering the stock have a positive outlook on its future performance. A “Buy” rating implies that analysts expect Oracle to deliver favorable results and growth in the coming months.
Stock Target Advisor’s Analysis: Stock Target Advisor conducts its own analysis of Oracle Corporation’s stock and classifies it as “Slightly Bullish.” This slightly bullish outlook is based on 10 positive signals and 6 negative signals. These signals are derived from various sources, including technical indicators, financial data, and market trends. The “Slightly Bullish” stance suggests that, according to their analysis, Oracle Corporation is expected to perform moderately well in the near future.
Recent Stock Performance: As of the last closing, Oracle Corporation’s stock was trading at USD 126.71. Over the past week, the stock price has experienced a notable increase of +4.78%, indicating a positive short-term performance. Furthermore, over the past month, the stock has demonstrated resilience with a substantial gain of +12.07%. Importantly, over the last year, Oracle’s stock has shown remarkable strength, soaring by +66.92%, suggesting robust long-term growth potential.